Abstract:Genetics is estimated to account for 50% of Coronary Artery Disease (CAD) risk. Genome-Wide Association Studies (GWAS) have revealed 100s of genomic loci which are associated with CAD (1). However, moving from GWAS signals to causal genes has proved challenging, slowing progress in developing interventions for CAD and other diseases. The greatest challenge in interpreting GWAS data is that only 10% of variants are in protein-coding regions and 90% are in "non-coding" genomic regions. Many of these non-coding variants are found in regulatory elements such as enhancers. Enhancers are distal regulatory elements that bind transcription factors and regulate genes up to 1 million base pairs away. This is achieved by DNA looping bringing enhancers into physical proximity with target genes. However, it is not possible to predict which gene(s) a given enhancer will regulate based on genomic location alone. We aimed to develop a generalisable workflow to solve CAD GWAS signals accurately and sensitively, by identifying causal enhancer SNPs and linking them mechanistically to output genes in a cell-type specific manner. We combined cell-specific epigenomic mapping with machine learning to prioritise 21,959 SNPs from 861 candidate CAD loci, in endothelial cells (HUVECs) and smooth muscle cells (HCASMCs). Micro-Capture-C (MCC) was used to resolve enhancer-promoter interactions at base-pair resolution (2). MNase footprinting determined differential transcription factor binding at specific enhancer SNPs. In HCASMCs, 20 putative enhancers containing CAD SNPs were found to interact with 32 genes, and in HUVECs 25 enhancers interacted with 48 genes. These genes were enriched for pathways including TGFb signalling, RUNX3 activity, and MAPK6/MAPK4 signalling. To prove causality at specific loci, heterozygous SNPs were identified in the individual primary cell lines. The interaction frequency at these elements was statistically compared between risk and non-risk alleles. For example, at the 9p21.3 locus, an enhancer containing a non-risk T allele was found to interact more strongly with the CDKN2B gene, compared to the risk G allele. Interestingly, this imbalance between allele interaction was potentiated by stimulation with TGFb, a key mediator in atherosclerosis. Furthermore, the transcription factor footprint at the SNP location was altered by the risk allele, indicating the mechanistic cause of the CAD-associated change in CDKN2B expression. We demonstrate a combined computational and experimental approach to identify causal non-coding variants in CAD risk loci, at scale. Among the key outputs of this study is the identification of the risk variant (rs1537373), output gene (CDKN2B), and specific cell type (HCASMC) underlying the 9p21.3 locus association with CAD risk. Using this approach to translate GWAS signals into cell-type specific outputs genes, will lead to a better understanding of the pathogenesis of CAD, and new therapeutic opportunities.

Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease

Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank

Large-scale genome-wide association study of coronary artery disease in genetically diverse populations

A Large-Scale Multi-Ethnic Genome-Wide Association Study of Coronary Artery Disease

Genetics of 35 blood and urine biomarkers in the UK Biobank

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

Micro-capture-C in vessel wall cell types identifies mechanisms underlying coronary artery disease susceptibility loci

Novel Common Variants Associated with Body Mass Index and Coronary Artery Disease Detected Using a Pleiotropic Cfdr Method.

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.

Multitrait Genome-Wide Analysis in the UK Biobank Reveals Novel and Distinct Variants Influencing Cardiovascular Traits in Africans and Europeans

Convergence of coronary artery disease genes onto endothelial cell programs

Genome-wide association studies found CCDC7 and ITGB1 associated with diabetic retinopathy

Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

Genome-wide Linkage Scans for Fasting Glucose , Insulin , and Insulin Resistance in the National Heart , Lung , and Blood Institute Family Blood Pressure Program Evidence of Linkages to Chromosome 7 Q 36 and 19 Q 13 from Meta-Analysis

Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels

Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease

Discovery and Refinement of Genetic Loci Associated with Cardiometabolic Risk Using Dense Imputation Maps

A Comprehensive 1000 Genomes-based Genome-Wide Association Meta-Analysis of Coronary Artery Disease

Genome-wide discovery for diabetes-dependent triglycerides-associated loci